SCHEMBL5169239

SCHEMBL5169239

CC(C)CCCN(C)CCCCC[C@H]1C[C@]2(C)[C@@H](O)CC[C@H]2[C@@H]2CCc3cc(O)ccc3[C@@H]12

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 13/20 0.70
ESR2 Q92731 9/20 0.70
HSD17B10 Q99714 3/20 0.51
LMNA P02545 2/20 0.51
TSHR P16473 2/20 0.51
CYP1A2 P05177 1/20 0.51
CYP2C9 P11712 1/20 0.51
CYP2C19 P33261 1/20 0.51
HIF1A Q16665 1/20 0.51
MEN1 O00255 1/20 0.51
KMT2A Q03164 1/20 0.51
SLC22A1 O15245 1/20 0.51
AKR1B10 O60218 1/20 0.51
SLC22A3 O75751 1/20 0.51
ABCB11 O95342 1/20 0.51
ESRRB O95718 1/20 0.51
ALDH1A1 P00352 1/20 0.51
NR3C1 P04150 1/20 0.51
SHBG P04278 1/20 0.51
PGR P06401 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5167440 0.91 ESR1 (0.74) ESR1ESR2HSD17B10LMNATSHR
SCHEMBL5166439 0.87 ESR1 (0.68) ESR1ESR2HSD17B10LMNATSHR
SCHEMBL5167175 0.86 ESR1 (0.67) ESR1ESR2HSD17B10LMNATSHR
SCHEMBL5167748 0.86 ESR1 (0.67) ESR1ESR2HSD17B10LMNATSHR
SCHEMBL5168581 0.86 ESR1 (0.67) ESR1ESR2HSD17B10LMNATSHR
SCHEMBL5165547 0.86 ESR1 (0.67) ESR1ESR2HSD17B10LMNATSHR
SCHEMBL5169580 0.86 ESR1 (0.67) ESR1ESR2HSD17B10LMNATSHR
SCHEMBL5167011 0.86 ESR1 (0.67) ESR1ESR2HSD17B10LMNATSHR
SCHEMBL5166406 0.86 ESR1 (0.67) ESR1ESR2HSD17B10LMNATSHR
SCHEMBL5165490 0.86 ESR1 (0.67) ESR1ESR2HSD17B10LMNATSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1187846-B1 11BETA LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11BETA LONG-CHAIN SUBSTITUTED ESTRATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS BAYER SCHERING PHARMA AG (DE) 2007-04-18 EP claimed
US-6790842-B1 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS SCHERING AKTIENGESELLSCHAFT (DE) 2004-09-14 US claimed
EP-1187846-B1 11BETA LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11BETA LONG-CHAIN SUBSTITUTED ESTRATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS BAYER SCHERING PHARMA AG (DE) 2007-04-18 EP disclosed
US-6790842-B1 11β LONG-CHAIN SUBSTITUTED ESTRATRIENES, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL PREPARATIONS CONTAINING SAID 11β LONG-CHAIN SUBSTITUTED ESTATRIENES, AND THEIR USE FOR PRODUCING MEDICAMENTS SCHERING AKTIENGESELLSCHAFT (DE) 2004-09-14 US disclosed